Welcome to our dedicated page for Gaxos.AI news (Ticker: GXAI), a resource for investors and traders seeking the latest updates and insights on Gaxos.AI stock.
Gaxos.AI Inc (GXAI) delivers cutting-edge AI solutions transforming digital well-being and gaming innovation. This hub provides investors and industry observers with essential updates on the company's advancements in empathetic technology and generative AI tools.
Access official press releases covering product launches, strategic partnerships, and operational milestones. Stay informed about Gaxos Labs developments for game creators and wellness application breakthroughs that redefine human-AI interaction.
Our curated news collection enables efficient tracking of GXAI's market position in AI-driven healthcare solutions and gaming infrastructure. Discover updates on licensing agreements, technology integrations, and leadership initiatives shaping the future of human-centered artificial intelligence.
Bookmark this page for real-time access to verified corporate announcements. Regularly updated content ensures you never miss critical developments from this pioneer in empathetic AI solutions across multiple industries.
Gaxos.ai Inc. (NASDAQ: GXAI), an AI applications developer, has announced a definitive agreement for the exercise of existing warrants. The agreement involves:
- Purchase of 1,256,734 shares of common stock
- Reduced exercise price from $5.50 to $2.58 per share
- Issuance of new unregistered warrants for 2,513,468 shares
- New warrants exercisable at $2.33 per share
The offering is expected to close around September 23, 2024, generating approximately $3.24 million in gross proceeds. Gaxos plans to use the net proceeds for working capital and general corporate purposes. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
Gaxos.ai, an artificial intelligence applications developer, has announced its participation in the Unite 2024 Conference from September 18th to 20th in Barcelona, Spain. This event, organized by Unity, brings together development communities, gamers, and industry leaders.
CEO Vadim Mats expressed enthusiasm about the opportunity to engage with key stakeholders and foster relationships that could drive growth for Gaxos' AI offerings. The company's presence at this significant industry gathering underscores its commitment to expanding its reach and influence in the AI sector.
Interested parties can arrange meetings with Gaxos representatives or make press inquiries by contacting press@gaxos.ai.
Gaxos.ai, an artificial intelligence applications developer, has announced its participation in two major gaming conferences in Cologne, Germany. The company will attend the Devcom Developer Conference from August 18th to 20th and the Gamescom Conference from August 21st to 25th, 2024.
CEO Vadim Mats expressed enthusiasm about the opportunity to engage with developers, industry leaders, and gamers. Gaxos aims to establish meaningful connections and grow its AI product for game developers and publishers. Interested parties can arrange meetings or press inquiries by emailing press@gaxos.ai.
Gaxos.ai has announced the commercial launch of Gaxos Health, marking its transition from development to revenue generation. The company recorded its initial revenue this week, signaling a significant milestone. Gaxos Health aims to optimize human performance through personalized health and wellness plans using science and technology.
The offering includes biomarker testing, customized nutrition plans, fitness routines, supplement plans, and live coaching. CEO Vadim Mats expressed enthusiasm about the launch, emphasizing the company's goal to become a leader in the personalized health services industry. Gaxos Health plans to expand its services with AI-enabled applications and additional health and wellness offerings.
Gaxos.ai (GXAI) has announced strategic partnerships with leading testing laboratories for its Gaxos Health division. This move is a significant step towards the commercial launch of their personalized health and wellness solutions. CEO Vadim Mats expressed excitement about the partnerships, highlighting their potential to transform the health and wellness experience for clients.
These collaborations are important for Gaxos Health's mission to optimize human performance through customized health plans and coaching, leveraging science and technology. The partnerships are expected to enhance Gaxos' ability to deliver impactful, personalized results to its clients, marking a pivotal milestone in the company's development.
On July 10, 2024, Gaxos.AI, a firm specializing in AI applications, announced a partnership with Meshy to integrate AI-generated 3D models into its solutions for game developers and publishers. This collaboration aims to deliver high-quality 3D assets, enhancing the toolkit available to game developers. Vadim Mats, CEO of Gaxos.AI, expressed enthusiasm about the partnership's potential to make their product an essential resource for the gaming industry. Ethan Hu, CEO of Meshy, highlighted the opportunity to provide innovative tools that simplify the creation of detailed and immersive 3D models for users.
Gaxos.AI has announced the successful completion of its AI solution development for game developers and publishers. The solution aims to enhance revenue opportunities and expedite game development processes. The AI product is currently in closed beta, being tested by independent developers. Key features include AI-powered creativity, reducing asset development time from hours to minutes, seamless integration with Unity and upcoming support for Unreal Engine, dynamic content generation through User-Generated-AI-Content (UGAiC), and customized solutions with tailored AI models and consulting services. The company aims to leverage this advancement to deliver shareholder value.
FAQ
What is the current stock price of Gaxos.AI (GXAI)?
What is the market cap of Gaxos.AI (GXAI)?
